Mitotan
|
|
Mitotan Eigenschaften
- Schmelzpunkt:
- 77-78 °C(lit.)
- Siedepunkt:
- 405.59°C (rough estimate)
- Dichte
- 1.3118 (rough estimate)
- Brechungsindex
- 1.6000 (estimate)
- storage temp.
- Inert atmosphere,Room Temperature
- L?slichkeit
- DMSO: soluble20mg/mL, clear
- Aggregatzustand
- powder
- Farbe
- white to beige
- Wasserl?slichkeit
- <0.1 g/100 mL at 24 ºC
- Merck
- 13,6237 / 13,6237
- BRN
- 2056007
- InChI
- InChI=1S/C14H10Cl4/c15-10-7-5-9(6-8-10)13(14(17)18)11-3-1-2-4-12(11)16/h1-8,13-14H
- InChIKey
- JWBOIMRXGHLCPP-UHFFFAOYSA-N
- SMILES
- C1(Cl)=CC=CC=C1C(C1=CC=C(Cl)C=C1)C(Cl)Cl
- CAS Datenbank
- 53-19-0(CAS DataBase Reference)
- NIST chemische Informationen
- Mitotane(53-19-0)
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
Kennzeichnung gef?hrlicher | Xn | ||
---|---|---|---|
R-S?tze: | 40 | ||
S-S?tze: | 36/37 | ||
RIDADR | 3249 | ||
WGK Germany | 3 | ||
RTECS-Nr. | KH7880000 | ||
HazardClass | 6.1(b) | ||
PackingGroup | III | ||
HS Code | 2903990002 | ||
Giftige Stoffe Daten | 53-19-0(Hazardous Substances Data) |
Bildanzeige (GHS) |
![]() |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alarmwort | Warnung | ||||||||||||||
Gefahrenhinweise |
|
||||||||||||||
Sicherheit |
|
Mitotan Chemische Eigenschaften,Einsatz,Produktion Methoden
R-S?tze Betriebsanweisung:
R40:Verdacht auf krebserzeugende Wirkung.S-S?tze Betriebsanweisung:
S36/37:Bei der Arbeit geeignete Schutzhandschuhe und Schutzkleidung tragen.Beschreibung
Mitotane is an inhibitor of steroidogenesis that suppresses the growth of adrenocortical cells. It blocks the expression of several genes that encode proteins involved in steroidogenesis and disrupts mitochondrial respiratory chain activity in human adrenocortical cells. Mitotane has anti-neoplastic actions, alone or in combination with other compounds, and suppresses cortisol synthesis, although it also has significant toxicity in the gastrointestinal tract and nervous system. It is effective against adrenocortical carcinoma and Cushing’s Syndrome in clinical trials.Chemische Eigenschaften
Crystalline SolidVerwenden
Mitotane is an inhibitor of steroidogenesis that suppresses the growth of adrenocortical cells. It blocks the expression of several genes that encode proteins involved in steroidogenesis and disrupts mitochondrial respiratory chain activity in human adrenocortical cells. Mitotane has anti-neoplastic actions, alone or in combination with other compounds, and suppresses cortisol synthesis, although it also has significant toxicity in the gastrointestinal tract and nervous system. It is effective against adrenocortical carcinoma and Cushing’s Syndrome in clinical trials.Indications
Mitotane (Lysodren) produces selective atrophy of the zona fasciculata and zona reticularis, which results in a decrease in the secretion of 17-hydroxycorticosteroids. Direct inhibition of cholesterol side-chain cleavage and 11/18-hydroxylase activities has also been demonstrated.Allgemeine Beschreibung
Colorless powder.Air & Water Reaktionen
Insoluble in water.Reaktivit?t anzeigen
Mitotan dehydrohalogenates with strong alkalis. Simple aromatic halogenated organic compounds are very unreactive; halogenated aliphatic compounds are moderately or very reactive. For both subgroups, reactivity generally decreases with increased degree of substitution of halogen for hydrogen atoms. Materials in this group are incompatible with strong oxidizing and reducing agents. Also, they are incompatible with many amines, nitrides, azo/diazo compounds, alkali metals, and epoxides.Brandgefahr
Flash point data for Mitotan are not available. Mitotan is probably combustible.Pharmakologie
Mitotane, a derivative of the insecticide DDT, quickly lowers the level of corticosteroids, and is metabolized in the blood and urine and used on non-operable metastatic prostate carcinomas. Synonyms of this drug are lysodren and others.Clinical Use
Mitotane is the drug of choice for the treatment of primary adrenal carcinoma when surgery or radiation therapy is not feasible. Its effectiveness in curtailing adrenal activity is due to an action on adrenocortical mitochondria to impair cytochrome P450 steps in steroid biosynthesis. Mitotane requires metabolic transformation to exert its therapeutic action, and the differential ability of tumors to metabolize the drug may determine its clinical effectiveness. It is advised to measure serum mitotane levels and urinary free cortisol excretion to ensure adequate therapeutic concentrations. Mitotane increases circulating cholesterol by inhibiting cytochrome P450–mediated reactions and therefore contributes to the cardiovascular events that are a significant cause of mortality in untreated Cushing’s syndrome.Mitotane, being closely related to the organochlorine insecticides, shares its inductive effects on the liver microsomal drug-metabolizing enzyme system, and its use may therefore alter the requirement for concomitantly administered drugs that are also metabolized by this pathway.
Nebenwirkungen
Mitotane is capable of inducing remission of Cushing’s disease, but only after several weeks of therapy and at the price of severe gastrointestinal distress. Moreover, more than half of patients relapse following cessation of therapy. Other side effects include lethargy, mental confusion, skin rashes, and altered hepatic function. Being a lipid-soluble substance, mitotane remains stored in body tissues for extended periods. This may account for the marked patient-to-patient variability in its therapeutic and/or toxic effects.l?uterung methode
Purify Mitotane by recrystallisation from pentane, MeOH or EtOH. It is soluble in isooctane and CCl4. [Haller et al. J Am Chem Soc 67 1600 1945, Beilstein 5 IV 1883.]Mitotan Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Mitotan Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 307)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Shijiazhuang Dingmin Pharmaceutical Sciences Co., Ltd. | +86-0311-67591193 +8615933619867 |
sales@dingminpharma.com | China | 254 | 58 |
Hebei Chuanghai Biotechnology Co., Ltd | +86-15531157085 +86-15531157085 |
abby@chuanghaibio.com | China | 8805 | 58 |
Hebei Mujin Biotechnology Co.,Ltd | +86 13288715578 +8613288715578 |
sales@hbmojin.com | China | 12826 | 58 |
Capot Chemical Co.,Ltd. | +86-(0)57185586718 +86-13336195806 |
sales@capot.com | China | 29730 | 60 |
Henan Tianfu Chemical Co.,Ltd. | +86-0371-55170693 +86-19937530512 |
info@tianfuchem.com | China | 21631 | 55 |
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 |
ivan@atkchemical.com | China | 33025 | 60 |
career henan chemical co | +86-0371-86658258 +8613203830695 |
sales@coreychem.com | China | 29866 | 58 |
SHANDONG ZHI SHANG CHEMICAL CO.LTD | +86 18953170293 |
sales@sdzschem.com | China | 2930 | 58 |
Xiamen AmoyChem Co., Ltd | +86-86-5926051114 +8618959220845 |
sales@amoychem.com | China | 6383 | 58 |
Hubei xin bonus chemical co. LTD | 86-13657291602 |
linda@hubeijusheng.com | CHINA | 22963 | 58 |
53-19-0(Mitotan)Verwandte Suche:
Dichlorethan
Ethan
Perfluorethan
1,2-Dichlorethan
Ethyl-4-hydroxybenzoat
Ethanol
ISOXADIFEN-ETHYL
Benzol
Ethylacetat
Ethylacrylat
Chlordifluormethan
Dichlorofluoroethane
Chlorethan
1,1-Dichlorethan
2,2,2,o,p'-Pentachlorethyliden-bisbenzol
Mitotan
- 2,4’-dichlorophenyldichlorethane
- 2,4'-Dichlorophenyldichlorethane
- Benzene, 1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]-
- Ethane, 1,1-dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)-
- Ethane, 2-(o-chlorophenyl)-2-(p-chlorophenyl)-1,1-dichloro-
- ethane,2,2-dichloro-1-(2-chlorophenyl)-1-(4-chlorophenyl)-
- Khlodithan
- NCI-C04933
- o,p’-dichlorodiphenyldichloroethane
- o,p'-Dichlorodiphenyldichloroethane
- Opeprim
- N-(3-Chloro-4-fluorophenyl)-7-Methoxy-6-(3-Morpholinopropoxy)quinazolin-4-aMine, 95+%
- 2, 4′-DDD, 100 μg/μL in acetone
- O,P'-DDD Solution, 100ppm
- 2,4′-DDD Standard
- 2,4'-DDD solution, 100ppm
- 2-(2-CHLOROPHENYL)-2-(4-CHLOROPHENYL)-1,1-DICHLOROETHANE
- 2,2-(2-chlorophenyl)-2-(4-chlorophenyl)-1,1-dichloroethane
- 2,4'-TDE
- (2,4'-DICHLORODIPHENYL)DICHLOROETHANE
- 1,1-DICHLORO-2-(O-CHLOROPHENYL)-2-(P-CHLOROPHENYL)ETHANE
- 1,1-DICHLORO-2-(2-CHLOROPHENYL)-2-(4-CHLOROPHENYL)ETHANE
- 1,1-dichloro-2,2-bis(2,4'-dichlorophenyl)ethane
- 1-(2-CHLOROPHENYL)-1-(4-CHLOROPHENYL)-2,2-DICHLOROETHANE
- 1-chloro-2-(2,2-dichloro-1-(4-chlorophenyl)ethyl)benzene
- O,P'-TDE
- MITOTAN
- CB-313
- 'LGC' (1126)
- 1-(o-Chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane
- 1,1-dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)-ethan
- 1,1-Dichloro-2-(p-chlorophenyl)-2-(o-chlorophenyl)ethane
- 2,2,o,p-tetrachloroethylidenebisbenzene
- 2,4'-DDD PESTANAL, 250 MG (2-(2-CHLOROPH
- O,P'-DDD, 250MG, NEAT
- 2,4'-DDD, 1000MG, NEAT
- 1-(2-CHLOROPHENYL)-1-(4-CHLOROPHENYL)-2, 2-DICHLOROETHANE, 99+%
- 1-(2-CHLOROPHENYL)-1-(4-CHLOROPHENYL)-2,2-DICHLOROETHANE (2,4'-DDD)
- Peprin
- o,p'-DDD, CB-313, Lysodren,1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane
- 1,1-dichloro-2-(2-chlorophenyl)-2-(4-chlorophenyl)ethane solution
- 2,4'-ddd solution
- 2-(p-Chlorophenyl)-2-(o-chlorophenyl)-1,1-dichloroethane
- Benzene, 1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]- (9CI)
- Ethane, 1,1-dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)- (6CI, 7CI, 8CI)
- Lysordren
- 1-chloro-4-[2,2-dichloro-1-(2-chlorophenyl)ethyl]benzene
- 2,4'-DDD (=TDE)
- o.p'-DDD 250mg [53-19-0]
- 1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane,(2,4′-Dichlorodiphenyl)dichloroethane, o,p′-DDD, Mitotane
- Mitotane (500 mg)
- o,p'-DDD [2,4'-Dichlorodiphenyldichloroethane]
- Mitotane, USP
- Mitotane (Lysodren)
- (2,4μ-Dichlorodiphenyl)dichloroethane, 1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane, o,pμ-DDD, Mitotane
- (2,4μ-Dichlorodiphenyl)dichloroethane, o,pμ-DDD, Mitotane
- 1-chloro-2-(2,2-dichloro-1-(4-chlorophenyl)ethyl)-benzen
- 2-(o-chlorophenyl)-2-(p-chlorophenyl)-1,1-dichloro-ethan